Form 4: Aethlon Medical Director Forfeits Shares for Tax Withholding

Aethlon Medical Inc. Director Chetan Shah forfeited 1,786 shares of common stock to cover tax withholdings related to the conversion of restricted stock units.

Summary

• Chetan Shah, a Director of Aethlon Medical Inc. (AEMD), reported a transaction on June 30, 2025.
• The transaction involved the forfeiture of 1,786 shares of common stock.
• The forfeiture was executed to cover tax withholdings associated with the conversion of an aggregate of 4,465 vested and outstanding restricted stock units (RSUs) into common stock.
• The market price of the issuer's common stock at the time of forfeiture was $1.2 per share.
• Following this reported transaction, Chetan Shah beneficially owns 19,993 shares of common stock directly.
• The restricted stock units were part of a grant previously reported in a Form 4 filed on April 25, 2025.

Sentiment

Score: 5

Explanation: The transaction is a routine forfeiture of shares for tax withholding purposes upon RSU vesting, which is a standard and expected part of executive compensation and does not indicate positive or negative operational or financial performance.

Future Outlook

NA

Industry Context

This transaction is a routine insider compensation event, specifically the forfeiture of shares to cover tax obligations upon the vesting of restricted stock units. It does not reflect broader industry trends or competitive dynamics but is a standard practice in executive compensation across various industries.

Stakeholder Impact

• Shareholders: The transaction represents a standard compensation event for a director, with a minor reduction in the director's direct holdings due to tax obligations. The underlying RSU conversion would have a minimal dilutive effect, which is typical for equity compensation plans.

Key Dates

Keywords

Aethlon Medical, AEMD, Chetan Shah, Form 4, Insider Transaction, Share Forfeiture, Restricted Stock Units, Tax Withholding, Beneficial Ownership